// App-Quantinova.ai

119 : Predictors of Response in Patients with Ankylosing Spondylitis Treated with Infliximab or Golimumab in a Real-World Setting

Researchers

Presenter

  • Suneil Kapur

Principal Investigators

  • Michel Zummer

  • Francois Nantel

  • Allen Lehman

  • Cathy Tkaczyk

  • Michael Starr

  • Denis Choquette

  • Maqbool Sheriff

  • Wojciech Olszynski

  • Emmanouil Rampakakis

  • Eliofotisti Psaradellis

  • Brendan Osborne

  • Karina Maslova

Medical Centers

  • Universite de Montreal, Departement de medecine, Montreal,Canada

  • Nanaimo Regional Hospital, Nanaimo,Canada

  • Univ of Ottawa, Ottawa, Canada

  • University of Saskatchewan, Saskatoon, SK, Canada

  • McGill, Montreal, QC, Canada

Locations

  • Canada

Companies

  • JSS Medical Research

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ankylosing spondylitis

  • Rheumatoid arthritis

  • Psoriatic arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Infliximab

  • golimumab

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved